Medicine by media: Did a critical television documentary affect the prescribing of cyproterone-estradiol (Diane-35)?

CMAJ. Canadian Medical Association Journal

Volumn 173, Issue 11, 2005, Pages 1313-1315

  Mintzes, Barbara ^a   Morgan, Steve ^a   Bassett, Ken L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIANE; MACROLIDE; RETINOID; TETRACYCLINE;

ACNE; CLINICAL PRACTICE; CONSUMER; DECISION MAKING; DOCUMENTATION; DRUG EFFECT; DRUG MARKETING; DRUG SAFETY; DRUG USE; GENOTOXICITY; HUMAN; MASS MEDIUM; ORAL CONTRACEPTION; PHYSICIAN; PRESCRIPTION; RISK FACTOR; SHORT SURVEY; TELEVISION; TREATMENT FAILURE; VENOUS THROMBOEMBOLISM;

EID: 28244439274     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050567     Document Type: Short Survey

References (4)

1. Vasilakis-Scaramozza, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet 2001;358:1427-1429.
2. Kravitz R, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 2005;293:1995-2002.
3. Wooltorton E. Diane-35 (cyproterone acetate): safety concerns. CMAJ 2OO3;168(4):455-6.
4. Grilli R,Ramsay C, Minozzi S. Mass media interventions: effects on health services utilisation [review]. Cochrane Database Syst Rev 2002;(1):CD000389.